I型干扰素塑造肝硬化腹腔免疫并在感染时驱动caspase-5介导的颗粒体蛋白前体释放
研究探讨肝硬化患者腹腔巨噬细胞暴露于细菌DNA后I型干扰素产生及其对免疫反应、炎症小体活化和损伤相关分子模式释放的影响。体外实验显示大肠杆菌单链DNA诱导I型干扰素活性,感染时经gasdermin D以I型干扰素和caspase-5依赖方式释放颗粒体蛋白前体;77例自发性细菌性腹膜炎患者中较高血清颗粒体蛋白前体浓度提示较低90天无移植生存率。
要点
- 大肠杆菌单链DNA在腹腔巨噬细胞和单核细胞中诱导强I型干扰素活性。
- 巨噬细胞感染时经gasdermin D以I型干扰素和caspase-5依赖方式释放颗粒体蛋白前体。
- 自发性细菌性腹膜炎患者较高血清颗粒体蛋白前体浓度提示较低90天无移植生存率。
核心结论
- I型干扰素塑造腹腔免疫反应并在自发性细菌性腹膜炎期间调控caspase-5介导的颗粒体蛋白前体释放。
研究设计与样本
- 体外研究:用大肠杆菌单链DNA、脂多糖和干扰素刺激肝硬化患者腹腔巨噬细胞,或用大肠杆菌、金黄色葡萄球菌和B组链球菌感染。
- 采用定量PCR、ELISA、蛋白质印迹和报告细胞检测细胞因子释放、炎症小体活化和损伤相关分子模式释放,使用原代腹腔巨噬细胞、单核细胞和caspase缺陷THP-1巨噬细胞。
- 在77例自发性细菌性腹膜炎患者中分析血清颗粒体蛋白前体浓度与无移植生存率的相关性。
主要发现
- 大肠杆菌单链DNA在腹腔巨噬细胞和单核细胞中诱导强I型干扰素活性,增强脂多糖介导的肿瘤坏死因子产生而不诱导toll样受体4耐受。
- 体外巨噬细胞细菌感染期间,I型干扰素释放与IFN调节因子1/2及鸟苷酸结合蛋白2/5表达上调一致。
- 腹腔巨噬细胞暴露于大肠杆菌单链DNA后上调炎症小体相关蛋白和I型干扰素,细菌感染后释放白细胞介素-1β。
- 小鼠巨噬细胞蛋白质组学筛选显示大肠杆菌感染期间颗粒体蛋白前体释放依赖caspase-11。
- 腹腔巨噬细胞和THP-1巨噬细胞感染金黄色葡萄球菌或大肠杆菌时经gasdermin D以I型干扰素和caspase-5依赖方式释放大量颗粒体蛋白前体。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Gut bacterial translocation contributes to immune dysfunction and spontaneous bacterial peritonitis (SBP) in cirrhosis. We hypothesized that exposure of peritoneal macrophages (PMs) to bacterial DNA results in type-I interferon (IFN) production, shaping subsequent immune responses, inflammasome activation, and the release of damage-associated molecular patterns (DAMPs). METHODS: PMs from patients with cirrhosis were stimulated with E. coli single-stranded DNA (ssDNA), lipopolysaccharide and IFN, or infected with E. coli, S. aureus, and Group B streptococcus in vitro. Cytokine release, inflammasome activation, and DAMP release were quantified by quantitative-PCR, ELISA, western blots, and reporter cells employing primary PMs, monocytes, and caspase-deficient THP-1 macrophages. Serum progranulin concentration was correlated with transplant-free survival in 77 patients with SBP. RESULTS: E. coli ssDNA induced strong type-I IFN activity in PMs and monocytes, priming them for enhanced lipopolysaccharide-mediated tumor necrosis factor production without inducing toll-like receptor 4 tolerance. During in vitro macrophage bacterial infection, type-I IFN release aligned with upregulated expression of IFN-regulatory factors (IRF)1/2 and guanylate binding proteins (GBP)2/5. PMs upregulated inflammasome-associated proteins and type-I IFN upon E. coli ssDNA exposure and released interleukin-1β upon bacterial infection. Proteomic screening in mouse macrophages revealed progranulin release as being caspase-11-dependent during E. coli infection. PMs and THP-1 macrophages released significant amounts of progranulin when infected with S. aureus or E. coli via gasdermin D in a type-I IFN- and caspase-5-dependent manner. During SBP, PMs upregulated IRF1, GBP2/5 and caspase-5 and higher serum progranulin concentrations were indicative of lower 90-day transplant-free survival after SBP. CONCLUSIONS: Type-I IFN shapes peritoneal immune responses and regulates caspase-5-mediated progranulin release during SBP. IMPACT AND IMPLICATIONS: Patients with cirrhosis exhibit impaired immune responses and increased susceptibility to bacterial infections. This study reveals that type-I interferon responses, triggered by pathogen-associated molecular patterns, are crucial in regulating macrophage activation and priming them for inflammatory responses. Additionally, we elucidate the mechanisms by which type-I interferons promote the release of progranulin from macrophages during spontaneous bacterial peritonitis. Our findings enhance understanding of how bacterial translocation affects immune responses, identify novel biomarkers for inflammasome activation during infections, and point to potential therapeutic targets.
引用
- Rooney M, Duduskar SN, Ghait M, et al. Type-I interferon shapes peritoneal immunity in cirrhosis and drives caspase-5-mediated progranulin release upon infection. J Hepatol. 2024. PMID: 38936554. doi:10.1016/j.jhep.2024.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。